Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Income Statement [Abstract]
Revenue under licensing agreements	$ 0	$ 925	$ 0	$ 925
Operating expenses:
Research and development expenses	19,366	15,744	37,131	29,285
General and administrative expenses	6,715	5,315	14,869	10,553
Total operating expenses	26,081	21,059	52,000	39,838
Loss from operations	(26,081)	(20,134)	(52,000)	(38,913)
Other income (expense):
Interest income	2,928	2,035	6,134	4,355
Interest expense	(1)	(4)	(3)	(7)
Other income	1,212	144	1,360	287
Other expense	(74)	(533)	(154)	(1,135)
Net loss	$ (22,016)	$ (18,492)	$ (44,663)	$ (35,413)
Per share information:
Net loss per share, basic (in dollars per share)	$ (1.05)	$ (1.09)	$ (2.12)	$ (2.09)
Net loss per share, diluted (in dollars per share)	$ (1.05)	$ (1.09)	$ (2.12)	$ (2.09)
Weighted-average shares of common stock outstanding, basic (in shares)	21,055,378	16,941,524	21,025,996	16,922,630
Weighted-average shares of common stock outstanding, diluted (in shares)	21,055,378	16,941,524	21,025,996	16,922,630